Cancer institute pilot program uses digital signatures for therapy evaluation program
The National Cancer Institute (NCI) and Bristol-Myers Squibb are using digital certificates that have been cross-certified by federal and industry public-key infrastructure bridges to take the paper out of paperwork in a cancer treatment evaluation program.
The program to enable digital signatures on electronic documents, which began this spring, could dramatically reduce the cost of clinical trials in the pharmaceutical industry and allow NCI to make fuller use of the government’s Personal Identity Verification card.